Inactive Instrument

News Sienna Biopharmaceuticals, Inc. Other OTC

Equities

SNNAQ

US82622H1086

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Motion for Asset Sale Approved for Sienna Biopharmaceuticals, Inc.	21-02-05	CI
Avro Life Sciences, Inc. entered into an agreement to acquire Certain Assets of Sienna Biopharmaceuticals, Inc. (OTCPK:SNNA.Q) for $0.1 million.	21-02-04	CI
Sebacia, Inc. completed the acquisition of all assets of Sienna Biopharmaceuticals, Inc. (OTCPK:SNNA.Q).	20-01-08	CI
Motion For Case Conversion Approved for Sienna Biopharmaceuticals, Inc.	19-12-18	CI
Sienna Biopharmaceuticals, Inc.(OTCPK:SNNA.Q) dropped from NASDAQ Composite Index	19-12-16	CI
Motion for Case Conversion Filed by Sienna Biopharmaceuticals, Inc.	19-12-12	CI
SIENNA BIOPHARMACEUTICALS, INC. : Other Events (form 8-K)	19-12-11	AQ
Motion for Asset Sale Approved for Sienna Biopharmaceuticals, Inc.	19-12-09	CI
Sebacia, Inc. entered into a sale purchase agreement to acquire all assets of Sienna Biopharmaceuticals, Inc. (OTCPK:SNNA.Q) for $1.7 million.	19-12-09	CI
Notice of Selection of Successful Bidder Filed by Sienna Biopharmaceuticals, Inc.	19-12-04	CI
Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding Procedures	19-11-14	GL
Sienna Biopharmaceuticals Announces Successful Appeal of Nasdaq Delisting Notice	19-11-14	GL
Bidding Procedure Approved for Sienna Biopharmaceuticals, Inc.	19-11-12	CI
Sienna Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-12	CI
Motion for Asset Sale Filed by Sienna Biopharmaceuticals, Inc.	19-10-22	CI
Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove Light Hair	19-10-07	GL
Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove Light Hair	19-10-07	CI
Sienna Biopharmaceuticals, Inc.(NasdaqGS:SNNA) dropped from S&P Global BMI Index	19-09-19	CI
Sienna Biopharmaceuticals, Inc.(NasdaqGS:SNNA) dropped from S&P TMI Index	19-09-19	CI
Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection Proceeding	19-09-17	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sienna Biopharmaceuticals, Inc. Other OTC

Equities

SNNAQ

US82622H1086

Summary

Filters